Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Too bad DNAG isn't marketing their version of DoggieDNA.
Response from IR for Bioserve alliance:
Hello Alfred - I spoke with Richard but we are not at the stage where we can devulge this kind of information. We will be developing a sales and marketing plan over the coming months.
thanks
Louise
Investor Relations
DNAPrint genomics, Inc.
V 941-366-3400
dnap@dnaprint.com
--------------------------------------------------------------------------------
From: XXX
Sent: Tue 10/9/2007 10:14 PM
To: dnap
Subject: Bioserve Strategic Alliance
Hi Louise. From the PR it seems like DNAG will be analyzing some 600,000 DNA samples. Where is the capital going to come from for the work being performed? I understand DNAG has limited resources and analyzing so many samples will take a lot of time, money, and resources. Is DNAG going to be compensated for their work?
Thanks in advance.
Frog, Stockboy, Iwant2be: I don't believe in pumping/bashing a stock without posting something factual. Frog posts information with his opinions about the company. I think thats more appropriate than just saying "the stock sucks" or the "stock is awesome". If you want to inform potential investors, you have to post facts along with your opinions. Its the only fair thing to do wouldn't you agree.
O/S of 652,409,215 sounds good to me with no increase since Sep 28th. Lets hope from here it goes down.
Stockhlder, did Bioserve mention how profit from each sample will be distribute? Who is funding this project?
To All:
What happened to this stock? I had it on my watch list when it was trading around the $1 range. I looked at their PRs and SEC filings. Why did the stock plummet? TIA/
stockhlder, you got a link to the CBS?
johnnyfiber,
"I feel good knowing one of our biggest competitors is now going to try and do something we've already done...and validated. DnaPrint has not only found biomarkers associated with disease...we've already associated toxicity, and response to drugs within the population. years ahead..."
Since competitors are now doing what DNAG has done, does DNAG have patents on this technology or can competitors compete with DNAG on this?
"Knockout mice" earn US-British trio Nobel Medicine prize
STOCKHOLM (AFP) - Mario Capecchi and Oliver Smithies of the United States and Martin Evans of Britain won the Nobel Medicine Prize on Monday for their work in creating "knockout mice," the 21st-century testbed for biomedical research.
The trio were honoured for discovering how to genetically manipulate mouse embryonic stem cells, leading to lab rodents that replicate human disease, the Nobel jury said in its citation.
Their "ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals ... led to the creation of an immensely powerful technology," the committee said.
The discovery is technically called gene targeting but is commonly known as gene "knockout."
Engineered mice provide researchers with a lab model that is yielding insights into the fundamentals of diseases ranging from Alzheimer's to cancer and the response to new drugs, the jury said.
"Gene targetting in mice has pervaded all fields of biomedicine. Its impact on the understanding of gene function and its benefits to mankind will continue to increase over many years to come," it said.
To date more than 10,000 mice genes -- approximately half of the genes in the mammalian genome -- have been knocked out.
Capecchi, born in Italy in 1937, is a human genetics and biology professor at the University of Utah, while British-born Smithies is a professor of pathology at the University of North Carolina.
Evans, born in 1941, is the director of the School of Biosciences and professor of mammalian gentics at Cardiff University in Britain.
Last year, the prize went to two US scientists, Andrew Fire and Craig Mello, for discovering how to silence malfunctioning genes, a breakthrough which could lead to an era of new therapies to reverse crippling disease.
The medicine prize is the first award to be announced in this year's Nobel season.
The physics prize is to be announced on Tuesday followed by the chemistry prize on Wednesday. The literature prize will be announced on Thursday and the peace prize on Friday.
The economics prize will wrap up the awards on October 15.
The Nobel prizes, founded by Swedish industrialist Alfred Nobel, were first awarded in 1901.
Nobel, the inventor of dynamite, died childless in 1896, dedicating his vast fortune to create "prizes to those who, during the preceding year, shall have conferred the greatest benefit on mankind."
Laureates receive a gold medal, a diploma and 10 million Swedish kronor (1.53 million dollars, 1.08 million euros) which can be split between up to three winners per prize.
The formal awarding of the prizes will take place in Stockholm on December 10.
Upcoming events:
The Small Value Cap next week
The Pharama conference in Atlantis
Police conference in New Orleans
Lets hope we hear something this month.
jever0, but DNAG is not marketing their doggieDNA.
Hey Preciouslife, can you shoot me an email? jkids210@yahoo.com
So where does DNAG stand with the DoggieDNA? Think we'll hear something for 3rd qtr?
we all are aware of the fact that this stock will trade the way it is until financing is secured. you don't need to state the obvious.
You're right. I just want to the financing to be sooner than later. Lets see what next weeks conference can do for us at the Small Value Cap.
How are bio-tech PPS usually calculated?
Lets hope that DNAG revenues by 2015 hits their target of $252 million a year. I can use $10 PPS.
stockhlder, i hope you're right this time.
IACP 114th Conference in New Orleans. DNAG will be there.
http://www.theiacpconference.org/exhibitor_list.cfm#D
How are they doing with the certification process?
We dropped below $2 now. This is not what I expected.
Question to All:
Can DNAG patent their SNP technology and AIMS? I remember some arguing that it was too broad to get a patent. Any opinions? Thanks.
chrisbaskett, I think most on the board are aware that if the company is unable to secure financing, it's all but over. Most here just believe that they are able to secure financing. If bio tech companies are able to raise up to $50 million on a pipeline then I think DNAG can too. DNAG also has a stream of revenue, not much but more than most starting bio techs.
I'm aware that this may go belly up if financing is not secured. I strongly believe though that they will secure financing.
chiggah,
it all comes down to the financing then. if richard can get the money or not. if he can't we go belly up. if he does then buckle up for the ride. good luck!
Preciouslife, it seems that a lot of companies are advancing in the field of genomics and dna. With the financing issue as an overhang, will we fall behind?
I took at look at some of the 10k back when the company first started. Previous management really sucked. It seemed like Richard did make some changes for the company. When he first came onboard he didn't even get paid, he got DNAG shares. At the time it increased to what 1.5 billion shares outstanding, so I guess the reverse split was needed. There has been good development since he came on board such as AncestryDNA, the Pharma with the EPO and CD59. It was also Richards idea to get into forensics to start generating revenues since drugs takes a while. The only bad thing he did was the dutchess financing.
DNAG IPO was in Feb 2001 at about $2.7 right? What was the outstanding share then? How much money did they raise? Thanks.
It is very complicated to be a long term investor in a BB stock. Its takes a great deal of research and fortitude to hold. However there are some that do make it. For example FRPT was trading as an .OB for years. I owned it when it was at .24 and then it did a reverse split. But patience did pay off. It is got listed on the NASDAQ and had a high of $30 PPS earlier this year. There are "hidden" gems in the penny world, but very few and rare. If you look at Dutchess website, they financed FRPT too.
stockhlder, do you have a link for the issued shares to dutchess where you got the info? thanks. i hope i didn't buy in too early.
so with 642 million shares outstanding and about 60 million shares are holders on this board, who's holding the rest??? its half a billion shares.
Do any of you think they will do another reverse split?
$116 billion... that would be great. I'm thinking more realisticly we can get $10PPS... Am I off or around the ball park. I don't think anything more than $10 PPS unless something happens.
chiggah,
why do you believe that the company will succeed? what "facts" has the company shown you that it can succeed? i see some good points and bad of course. the bad points is the fact that the company promised shareholders that it will not do a reverse split and yet it went through one. the company has minimal revenue. the company is also still stuck in the grasp of dutchess and is in a financial nightmare. the good points to the company is the fact that its seeking financing through creative ways through the euronext and with a bond. its pipeline has gotten a lot better from previous years since it form the pharma.
one thing that i still question is richards leadership. there isn't a lot of information on how successful he was. richard has been with the company for several years now and things are now barely getting started. the timelines they provided seem great but are they realistic, thats my question.
i'm long in the company, but i still must continuously do my dd. btw, i just recently started investing in biotechs. i used to invest mostly in large caps and in infrastructure companys and financial companies. biotechs are hard to invest in but the payoffs are the biggest i believe. the 90s was tech, and i believe the next ones are biotechs. with a growing retirement poplulation, bio techs will play a great role in improving health and quality of life.
Transfer Agent
Standard Registrar and Transfer Co., Inc.,
12528 South 1840 E.
Draper, UT 84020
(801) 571-8844
Has anyone called to get the most current O/S info? I will do it if no one has done it.
chiggah, you made some very good points, but it didn't answer some of my questions. i do appreciate the response though.
stockboy, I see in your old posts that you used to be long in dnag. at what point did it change? what promises have they failed to deliver? were they just late in delivering them or didn't deliver at all. please provide specific events please. thanks.
does anyone know the outstanding share as of today or have the ta contact info? thanks.
stockhlder101, i know you and a few here have been in this stock for years on end. it seems like mgt track record has been poor with a lot of broken promises, i.e. no reverse split. in 2005 when they had the $35 million financing from dutchess for 2 yrs, things seemed great yet now we're in a mess here. i have also read that our ancestry products were not even invented by the company but purchased. it seems like the company is only able to purchase others inventions, but cannot invent our own. i know you've been with dnag for 7 yrs, so has there been a lot of promises that are yet to be fulfilled? it seems like they have always promised sharedholders value, yet failed to delivered. don't get me wrong, i'm still holding my shares, however with their track record, where will we go from here??? opinions??? thanks.
I ask cause one of my friend from UBS said this when I told him about DNAG.
Al,
I struggle with this one, but interesting to watch.
Compared to its competitors (CRA, CDGN and ORCH) and its inception in
1998 at $4/share with great funding, it still has to launch a product of
success nor receive funding to achieve any remarkable revenue for its
efforts. Yes, I agree, it is a company on the move and in its R&D
phase...but, since 1998? It continues to live on borrowed monies,
derivatives and has been in default on its notes. Its institutional
investors are selling...Hmm? Every time DNAG CEO speaks, the stock
drops. If it were to strike big and this I mean to be $1/share in FY08,
it might be worth watching.
Recommendation: (1) I would place it on a watch list and continually
compare to its peer stocks and pipeline products. (2) Where you do buy
in FY08, prepare for a loss. (3) watch market sentiment to their CEO and
potential buy-out suitors, and (4) track institutional investor block
purchases or sales. This usually is an indication of trending.
stockholder, after 7 years why do you think DNAG will succeed now? any facts or reason for your belief. comparable companies has been doing better than us like orchid. thanks.
Souzagotcha, how did you come up with 45.76 PPS??? Thanks.